NYSE
$22.68▲ 0.07%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $12.25BShares out 5.400M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
10- 10.7Regular26.10.08 03:196-KKey event#●●●
Fresenius Medical Care AG
Fresenius Medical Care (FME) has appointed Shervin J. Korangy as the new CEO and Chair of the Management Board, effective October 12, 2026. Succeeding the current CEO Helen Giza, Korangy will lead the company's next phase, focusing on accelerating long-term profitable growth and advancing innovation.…more
$22.68+0.07%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.25Pre-market26.09.25 20:546-KKey event
Fresenius Medical Care AG
Fresenius Medical Care is refining its China commercial strategy by discontinuing the 4008A hemodialysis system and exiting its peritoneal dialysis business. These actions are expected to result in approximately €110 million in one-time costs, primarily impairment charges, to be recognized in the third quarter of 2026. The company does not expect these portfolio adjustments to significantly impact the future revenue outlook for its China business.…more
$22.68+0.07%vs prev closeView filingShare - 8.27Pre-market26.08.27 21:146-KKey event
Fresenius Medical Care AG
Fresenius Medical Care announced that a large-scale study of approximately 20,000 patients across eight European countries found that high-volume hemodiafiltration (HVHDF) is associated with a 28% lower relative risk of all-cause mortality compared to conventional high-flux hemodialysis. Patients receiving convection volumes above 23 liters per session showed a 33% lower risk of death, reinforcing the clinical value of HVHDF as a standard of care.…more
$22.68+0.07%vs prev closeView filingShare
9 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 3d agoOvernight26.10.22 16:50#●●●#●●●#●●●
Fresenius Medical Care Launches FDA-Cleared multiFiltratePRO in US
Fresenius Medical Care has launched its FDA-cleared multiFiltratePRO system in the U.S. for treating acute kidney injury. This rollout expands the availability of advanced continuous kidney replacement therapy options for hospital intensive care units.…more
$22.68+0.07%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.7Regular26.10.08 00:32
●●●●●●●● ●●●●● ●●●●●●
Fresenius Medical Care announced that Shervin J. Korangy will succeed Helen Giza as CEO and Chair of the Management Board, effective October 12, 2026. This leadership transition marks a change in the company's top executive management.…more
$22.68+0.07%vs prev closeShareBenzinga - 9.25Regular26.09.26 02:12
●●●●●●●● ●●●●● ●●●●●●
Fresenius Medical Care is refining its China commercial strategy by focusing on advanced dialysis technology while exiting the peritoneal dialysis sector. The company expects to incur approximately 110 million euros in one-time charges during the third quarter of 2026 due to these operational adjustments.…more
$22.68+0.07%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report